Jooyeon Jamie Im
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jooyeon Jamie Im has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- In-Uk Song
Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications - Hyeonseok Jeong
Department of Radiology Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea Seoul South Korea
2 shared publications - Seunghee Na
Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea
2 shared publications Woo-Young Ahn
2 shared publications- Yong-An Chung
Department of Nuclear Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea
2 shared publications Eunsol So
1 shared publication
Latest Publications
- Open Access
- 4 December 2025
- Published by Center for Open Science in PsyArXiv
A Systematic Review of Interoception in Substance Use Disorders
Purpose of Review Despite the growing number of studies on interoception in addiction research, a comprehensive review of these findings is still lacking. The goal of this paper was to conduct a systematic review of empirical studies to assess the evidence for interoceptive deficits in individuals with substance use disorders (SUDs), identify gaps in the existing literature, and propose directions for future research.Recent FindingsFrom 1,544 records identified in APA PsycINFO, PubMed, CINAHL, and Embase using predefined search terms, 39 studies met eligibility criteria. Of these, 14 examined alcohol use disorder, 12 heterogeneous substance use, 6 opioid use disorder, 4 smokers, 2 cocaine use disorder, and 1 cannabis use. With respect to interoceptive domains (accuracy, sensibility, awareness), 12 studies assessed accuracy only, 19 assessed sensibility only, and 8 measured both; only one study additionally evaluated interoceptive awareness. Behavioral tasks (e.g., heartbeat counting) and self-report questionnaires (e.g., Multidimensional Assessment of Interoceptive Awareness; MAIA) were the most common measures of interoceptive accuracy and sensibility, respectively. Neuroimaging work was scarce, with only four studies examining neural correlates.SummaryAcross studies of interoception in SUDs, the most consistent pattern is reduced interoceptive accuracy relative to healthy controls, particularly in alcohol use disorder where impairments were most robust, though findings for other substances showed greater variability. Evidence for interoceptive sensibility is mixed, and work on interoceptive awareness remains sparse. The literature is constrained by a narrow emphasis on two dimensions and by heavy reliance on the heartbeat counting task, which has been widely criticized for validity concerns. Future research should assess multiple interoceptive dimensions across modalities, develop and validate more robust measures, and address potential confounders such as smoking status.
- 4 December 2025
- Published by Center for Open Science in PsyArXiv
Open AccessA Systematic Review of Interoception in Substance Use Disorders
Purpose of Review Despite the growing number of studies on interoception in addiction research, a comprehensive review of these findings is still lacking. The goal of this paper was to conduct a systematic review of empirical studies to assess the evidence for interoceptive deficits in individuals with substance use disorders (SUDs), identify gaps in the existing literature, and propose directions for future research.Recent FindingsFrom 1,544 records identified in APA PsycINFO, PubMed, CINAHL, and Embase using predefined search terms, 39 studies met eligibility criteria. Of these, 14 examined alcohol use disorder, 12 heterogeneous substance use, 6 opioid use disorder, 4 smokers, 2 cocaine use disorder, and 1 cannabis use. With respect to interoceptive domains (accuracy, sensibility, awareness), 12 studies assessed accuracy only, 19 assessed sensibility only, and 8 measured both; only one study additionally evaluated interoceptive awareness. Behavioral tasks (e.g., heartbeat counting) and self-report questionnaires (e.g., Multidimensional Assessment of Interoceptive Awareness; MAIA) were the most common measures of interoceptive accuracy and sensibility, respectively. Neuroimaging work was scarce, with only four studies examining neural correlates.SummaryAcross studies of interoception in SUDs, the most consistent pattern is reduced interoceptive accuracy relative to healthy controls, particularly in alcohol use disorder where impairments were most robust, though findings for other substances showed greater variability. Evidence for interoceptive sensibility is mixed, and work on interoceptive awareness remains sparse. The literature is constrained by a narrow emphasis on two dimensions and by heavy reliance on the heartbeat counting task, which has been widely criticized for validity concerns. Future research should assess multiple interoceptive dimensions across modalities, develop and validate more robust measures, and address potential confounders such as smoking status.
- Open Access
Dynamic Brain Network Changes Associated with Successful Smoking Cessation
Background: Tobacco smoking continues to be a leading cause of preventable morbidity and mortality globally, with the success rate of unaided cessation remaining consistently low. Understanding the neurobiological mechanisms of smoking cessation is crucial for improving quit rates. However, there has been a lack of studies examining brain network changes associated with smoking cessation over time. In this study, we aimed to investigate longitudinal changes in the functional connectivity (FC) of large-scale brain networks underlying smoking cessation outcomes using resting-state functional magnetic resonance imaging (fMRI). Methods: A total of 98 treatment-seeking smokers participated in a 6-week cessation program and underwent resting-state fMRI scans before and after the intervention. Independent component analysis identified the salience network (SN), executive control network (ECN), and default mode network (DMN) components, and region of interest (ROI)-to-ROI FC was compared between successful and unsuccessful quitters using a group × time mixed-effects model. Correlations with smoking-related measures were explored. Results: Significant group-by-time interaction effects were found in FC, particularly involving connections between SN and ECN, as well as between the SN and DMN. Specifically, successful quitters exhibited greater baseline FC in the SN-ECN and SN-DMN circuits, which tended to normalize during the cessation process. Exploratory correlational analyses revealed trends suggesting that stronger pre-quit connectivity between the SN and ECN was associated with greater withdrawal severity and longer smoking history in successful quitters. Conclusions: Taken together, the normalization of initially elevated pre-quit FC in SN-ECN and SN-DMN circuits may reflect an adaptive neural process that supports successful withdrawal management and attentional reallocation during cessation. The identification of these neural substrates not only enhances our mechanistic understanding of smoking cessation over time but also underscores the need for targeted interventions that focus on these neural circuits to enhance quit outcomes.
Open AccessDynamic Brain Network Changes Associated with Successful Smoking Cessation
Background: Tobacco smoking continues to be a leading cause of preventable morbidity and mortality globally, with the success rate of unaided cessation remaining consistently low. Understanding the neurobiological mechanisms of smoking cessation is crucial for improving quit rates. However, there has been a lack of studies examining brain network changes associated with smoking cessation over time. In this study, we aimed to investigate longitudinal changes in the functional connectivity (FC) of large-scale brain networks underlying smoking cessation outcomes using resting-state functional magnetic resonance imaging (fMRI). Methods: A total of 98 treatment-seeking smokers participated in a 6-week cessation program and underwent resting-state fMRI scans before and after the intervention. Independent component analysis identified the salience network (SN), executive control network (ECN), and default mode network (DMN) components, and region of interest (ROI)-to-ROI FC was compared between successful and unsuccessful quitters using a group × time mixed-effects model. Correlations with smoking-related measures were explored. Results: Significant group-by-time interaction effects were found in FC, particularly involving connections between SN and ECN, as well as between the SN and DMN. Specifically, successful quitters exhibited greater baseline FC in the SN-ECN and SN-DMN circuits, which tended to normalize during the cessation process. Exploratory correlational analyses revealed trends suggesting that stronger pre-quit connectivity between the SN and ECN was associated with greater withdrawal severity and longer smoking history in successful quitters. Conclusions: Taken together, the normalization of initially elevated pre-quit FC in SN-ECN and SN-DMN circuits may reflect an adaptive neural process that supports successful withdrawal management and attentional reallocation during cessation. The identification of these neural substrates not only enhances our mechanistic understanding of smoking cessation over time but also underscores the need for targeted interventions that focus on these neural circuits to enhance quit outcomes.
- Open Access
- 1 October 2021
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 40 (4) , 512-519
A pilot clinical study of low-intensity transcranial focused ultrasound in Alzheimer’s disease
Purpose: Increasing attention has been paid to low-intensity transcranial focused ultrasound (tFUS) for its potential therapeutic effects in Alzheimer's disease (AD). While preclinical studies have shown promising therapeutic effects of low-intensity tFUS in AD models, its efficacy and safety remain unclear in humans. In this pilot study, we investigated the effects of low-intensity tFUS on blood-brain barrier opening, the regional cerebral metabolic rate of glucose (rCMRglu), and cognition in patients with AD.Methods: After receiving institutional review board approval, four patients with AD received tFUS to the hippocampus immediately after an intravenous injection of a microbubble ultrasound contrast agent. Sonication was delivered at low-intensity, at a pressure level below the threshold for blood-brain barrier opening. Patients underwent brain magnetic resonance imaging, 18F-fluoro-2-deoxyglucose positron emission tomography, and neuropsychological assessments before and after the tFUS procedure. A whole-brain voxel-wise paired t test was conducted to compare rCMRglu before and after tFUS.Results: The sonication, as anticipated, did not show evidence of active blood-brain barrier opening on T1 dynamic contrast-enhanced magnetic resonance imaging. rCMRglu in the superior frontal gyrus (P<0.001), middle cingulate gyrus (P<0.001), and fusiform gyrus increased after tFUS (P=0.001). Patients demonstrated mild improvement in measures of memory, executive, and global cognitive function following tFUS. No adverse events were reported.Conclusion: These results suggest that hippocampal sonication with low-intensity tFUS may have beneficial effects on cerebral glucose metabolism and cognitive function in patients with AD. Further larger studies are needed to confirm the therapeutic efficacy of tFUS in AD.
- 1 October 2021
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 40 (4) , 512-519
Open AccessA pilot clinical study of low-intensity transcranial focused ultrasound in Alzheimer’s disease
Purpose: Increasing attention has been paid to low-intensity transcranial focused ultrasound (tFUS) for its potential therapeutic effects in Alzheimer's disease (AD). While preclinical studies have shown promising therapeutic effects of low-intensity tFUS in AD models, its efficacy and safety remain unclear in humans. In this pilot study, we investigated the effects of low-intensity tFUS on blood-brain barrier opening, the regional cerebral metabolic rate of glucose (rCMRglu), and cognition in patients with AD.Methods: After receiving institutional review board approval, four patients with AD received tFUS to the hippocampus immediately after an intravenous injection of a microbubble ultrasound contrast agent. Sonication was delivered at low-intensity, at a pressure level below the threshold for blood-brain barrier opening. Patients underwent brain magnetic resonance imaging, 18F-fluoro-2-deoxyglucose positron emission tomography, and neuropsychological assessments before and after the tFUS procedure. A whole-brain voxel-wise paired t test was conducted to compare rCMRglu before and after tFUS.Results: The sonication, as anticipated, did not show evidence of active blood-brain barrier opening on T1 dynamic contrast-enhanced magnetic resonance imaging. rCMRglu in the superior frontal gyrus (P<0.001), middle cingulate gyrus (P<0.001), and fusiform gyrus increased after tFUS (P=0.001). Patients demonstrated mild improvement in measures of memory, executive, and global cognitive function following tFUS. No adverse events were reported.Conclusion: These results suggest that hippocampal sonication with low-intensity tFUS may have beneficial effects on cerebral glucose metabolism and cognitive function in patients with AD. Further larger studies are needed to confirm the therapeutic efficacy of tFUS in AD.
- 24 November 2019
- Published by Wiley in Journal of Neuroimaging
- Vol. 30 (2) , 161-164
Transcranial Direct Current Stimulation for the Treatment of Parkinson's Disease: Clinical and Regional Cerebral Blood Flow SPECT Outcomes
BACKGROUND AND PURPOSE: Over the course of treatment for Parkinson's disease (PD), the clinical effects of dopaminergic medication diminish and side effects emerge. Therefore, searching for new therapeutic alternatives or complementary treatments is required. Transcranial direct current stimulation (tDCS) could potentially complement the current therapeutic armamentarium, but only a few studies have investigated the therapeutic effects of tDCS in PD. The present pilot study aimed to investigate the effects of repeated tDCS treatment on motor symptoms and regional cerebral blood flow (rCBF) in patients with PD using single photon emission computed tomography (SPECT).METHODS: Four patients with PD received tDCS to the dorsolateral prefrontal cortex two times per week (anode F3/cathode F4, 2 mA for 30 minutes) over a period of 12 months. Patients underwent brain SPECT scans and clinical motor evaluation at baseline and 12‐month follow‐up. For SPECT data, voxel‐wise changes in rCBF were analyzed.RESULTS: There was no significant change of the motor severity scale, but the follow‐up SPECT showed significant hyperperfusion in the left superior frontal gyrus medial segment and left superior parietal lobule compared to baseline (P < .001).CONCLUSIONS: This study shows that tDCS application may improve rCBF in the frontal and parietal lobes in patients with PD, suggesting beneficial effects of tDCS on brain function. Our results are preliminary and further large‐scale studies are needed to confirm our findings.
- 24 November 2019
- Published by Wiley in Journal of Neuroimaging
- Vol. 30 (2) , 161-164
Transcranial Direct Current Stimulation for the Treatment of Parkinson's Disease: Clinical and Regional Cerebral Blood Flow SPECT Outcomes
BACKGROUND AND PURPOSE: Over the course of treatment for Parkinson's disease (PD), the clinical effects of dopaminergic medication diminish and side effects emerge. Therefore, searching for new therapeutic alternatives or complementary treatments is required. Transcranial direct current stimulation (tDCS) could potentially complement the current therapeutic armamentarium, but only a few studies have investigated the therapeutic effects of tDCS in PD. The present pilot study aimed to investigate the effects of repeated tDCS treatment on motor symptoms and regional cerebral blood flow (rCBF) in patients with PD using single photon emission computed tomography (SPECT).METHODS: Four patients with PD received tDCS to the dorsolateral prefrontal cortex two times per week (anode F3/cathode F4, 2 mA for 30 minutes) over a period of 12 months. Patients underwent brain SPECT scans and clinical motor evaluation at baseline and 12‐month follow‐up. For SPECT data, voxel‐wise changes in rCBF were analyzed.RESULTS: There was no significant change of the motor severity scale, but the follow‐up SPECT showed significant hyperperfusion in the left superior frontal gyrus medial segment and left superior parietal lobule compared to baseline (P < .001).CONCLUSIONS: This study shows that tDCS application may improve rCBF in the frontal and parietal lobes in patients with PD, suggesting beneficial effects of tDCS on brain function. Our results are preliminary and further large‐scale studies are needed to confirm our findings.
- 28 August 2019
- Published by Wiley in Journal of Neuroimaging
- Vol. 29 (6) , 707-711
Neuroprotective Effects of Rasagiline in Parkinson's Disease: A Regional Cerebral Blood Flow Study
BACKGROUND AND PURPOSE: Despite accumulating evidence for the clinical efficacy and neuroprotective properties of rasagiline in Parkinson's disease (PD), effects of rasagiline on brain perfusion in PD patients have not been elucidated. The present study aimed to investigate the effects of rasagiline on regional cerebral blood flow (rCBF) in patients with PD using single‐photon emission computed tomography (SPECT).METHODS: A total of 44 PD patients were recruited and treated with dopamine agonist, either alone or in combination with levodopa. Twenty‐two of these patients (referred to as the rasagiline group) additionally received rasagiline (1 mg/day). All patients underwent brain SPECT scans and clinical assessments at baseline and follow‐up visits. The mean follow‐up period was 2.2 years. Changes in rCBF were compared between the rasagiline group and the comparison group in a voxel‐wise manner.RESULTS: Annual change in Unified Parkinson's Disease Rating Scale motor score was lower in the rasagiline group compared to the comparison group (P = .01). A significant group‐by‐time interaction effect on rCBF was found in the right precuneus (P = .001), where rCBF was decreased in the comparison group and remained stable in the rasagiline group.CONCLUSIONS: Our results show that adjunctive rasagiline treatment had beneficial effects on perfusion in the precuneus of PD patients, suggesting potential neuroprotective effects.
- 28 August 2019
- Published by Wiley in Journal of Neuroimaging
- Vol. 29 (6) , 707-711
Neuroprotective Effects of Rasagiline in Parkinson's Disease: A Regional Cerebral Blood Flow Study
BACKGROUND AND PURPOSE: Despite accumulating evidence for the clinical efficacy and neuroprotective properties of rasagiline in Parkinson's disease (PD), effects of rasagiline on brain perfusion in PD patients have not been elucidated. The present study aimed to investigate the effects of rasagiline on regional cerebral blood flow (rCBF) in patients with PD using single‐photon emission computed tomography (SPECT).METHODS: A total of 44 PD patients were recruited and treated with dopamine agonist, either alone or in combination with levodopa. Twenty‐two of these patients (referred to as the rasagiline group) additionally received rasagiline (1 mg/day). All patients underwent brain SPECT scans and clinical assessments at baseline and follow‐up visits. The mean follow‐up period was 2.2 years. Changes in rCBF were compared between the rasagiline group and the comparison group in a voxel‐wise manner.RESULTS: Annual change in Unified Parkinson's Disease Rating Scale motor score was lower in the rasagiline group compared to the comparison group (P = .01). A significant group‐by‐time interaction effect on rCBF was found in the right precuneus (P = .001), where rCBF was decreased in the comparison group and remained stable in the rasagiline group.CONCLUSIONS: Our results show that adjunctive rasagiline treatment had beneficial effects on perfusion in the precuneus of PD patients, suggesting potential neuroprotective effects.